PCN74 COST-EFFECTIVENESS OF NEXT-GENERATION SEQUENCING...

Value in Health 2019 / 05 Vol. 22

PCN74 COST-EFFECTIVENESS OF NEXT-GENERATION SEQUENCING MINIMAL RESIDUAL DISEASE TESTING PRIOR TO STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA

Zimmermann, M., Eckert, B., Carlson, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.198
Date:
May, 2019
File:
PDF, 382 KB
2019
Conversion to is in progress
Conversion to is failed